Excessive IL-22 may also reduce the number of intestinal stem cells (ISCs), affecting the regenerative capacity of the intestinal epithelium, which may exacerbate intestinal mucosal injury in IBD (74, 75). Here, IL22 is linked to irritable bowel syndrome.